Show simple item record

dc.contributor.author执行委员会, 115
dc.coverage.spatial日内瓦en
dc.date.accessioned2012-04-20T01:59:28Z
dc.date.available2012-04-20T01:59:28Z
dc.date.issued2005
dc.identifier.govdocEB115/32
dc.identifier.urihttps://iris.who.int/handle/10665/25352
dc.description执行委员会第一一五届会议,临时议程项目4.9en
dc.language.isozhen
dc.publisher世界卫生组织en
dc.relation.urihttps://iris.who.int/handle/10665/25352
dc.subjectAntiretroviral therapyen
dc.subjectPharmaceutical productsen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshDrugs, Genericen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Industryen
dc.subject.meshCommerceen
dc.subject.meshDeveloping Countriesen
dc.title抗逆转录病毒药物与发展中国家:秘书处的报告en
dc.typeGoverning body documentsen
dc.subject.meshqualifiereconomicsen
dc.subject.meshqualifierlegislation and jurisprudenceen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiersupply and distributionen
dc.subject.meshqualifiertrendsen
who.relation.languageVersion10665/20227en
who.relation.languageVersion10665/22366en
who.relation.languageVersion10665/68824en
who.relation.languageVersion10665/22279en
who.relation.languageVersion10665/21649en
who.relation.languageVersion10665/20757en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB115
    17-25 January 2005

Show simple item record